| 參考價 | ￥660.00 |
| 規(guī)格 | 100mg | 660元 | 10000 支可售 |
產(chǎn)品簡介
| CAS號 | 633-65-8 | 產(chǎn)地 | 國產(chǎn) |
| 規(guī)格 | 100mg | 級別 | 化工級 |
| 證書 | ISO系列證書 |
Berberine chloride 是一種生物堿，常用作抗生su。Berberine chloride 誘導(dǎo)活性氧 (ROS) 生成并抑制 DNA 拓?fù)洚悩?gòu)酶 (topoisomerase)。
生物活性
Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1].
IC50 & Target
體外研究(In Vitro)
Berberine (1.25-160 μM; 72 hours) has potential inhibitory effects on the proliferation of four colorectal carcinoma cell lines LoVo, HCT116, SW480, and HT-29[1].
Berberine (1.25-160 μM; 24-72 hours) induces a time- and dose-dependent inhibition of LoVo cell growth[1].
LoVo cells are exposure to Berberine (10-80 μM) for 24 h. Cell cycle analysis of 40 μM Berberine-treated LoVo cells by flow cytometry shows accumulation of cells in the G2/M phase[1].
Berberine (10-80 μM) suppresses cyclin B1, cdc2 and cdc25c protein expression after 24 h, especially at the dose of 80.0 μM[1].
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Proliferation Assay[1]
| Cell Line: | Four colorectal carcinoma cell lines LoVo, HCT116, SW480, and HT-29 |
| Concentration: | 1.25, 2.5, 5, 10, 20, 40, 80, and 160 μM |
| Incubation Time: | 72 hours |
| Result: | Inhibited the proliferation of four cell lines. The IC50 ranged from 40.8±4.1 μM (LoVo) to 98.6±2.9 μM (HCT116). |
體內(nèi)研究(In Vivo)
Berberine (10, 30, or 50 mg/kg/day; gastrointestinal gavage; for 10 consecutive days) inhibits the growth of human colorectal adenocarcinoma in vivo. Berberine at doses of 30 and 50 mg/kg/day taken by gastrointestinal gavage shows inhibitory rates of 33.1% and 45.3% on the human colorectal adenocarcinoma xenograft growth in nude mice[1].
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| Animal Model: | 5-week-old BALB/c nu/nu mice with human colorectal adenocarcinoma LoVo xenografts[1] |
| Dosage: | 10, 30, or 50 mg/kg/day |
| Administration: | Gastrointestinal gavage; for 10 consecutive days |
| Result: | Showed inhibitory rates of 33.1 % and 45.3 % at doses of 30 and 50 mg/kg/day. |
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT03609892 | Xijing Hospital of Digestive Diseases | August 1, 2018 | Phase 4 | |
| NCT02226185 | Shanghai Jiao Tong University School of Medicine | November 2014 | Phase 2|Phase 3 | |
| NCT03378934 | Peking Union Medical College Hospital | September 26, 2018 | Phase 4 |
分子量：371.81
性狀：Solid
Formula：C20H18ClNO4
CAS 號：633-65-8
中文名稱：鹽酸小檗jian；鹽酸黃連su；鹽酸黃蓮素
運(yùn)輸條件：Room temperature in continental US; may vary elsewhere.
儲存方式：
4°C, sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
溶解性數(shù)據(jù)
DMSO : 12.5 mg/mL (33.62 mM; Need ultrasonic)
H2O : < 0.1 mg/mL (ultrasonic) (insoluble)
| 濃度溶劑體積質(zhì)量 | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.6895 mL | 13.4477 mL | 26.8955 mL |
| 5 mM | 0.5379 mL | 2.6895 mL | 5.3791 mL |
| 10 mM | 0.2690 mL | 1.3448 mL | 2.6895 mL |
請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液；一旦配成溶液，請分裝保存，避免反復(fù)凍融造成的產(chǎn)品失效。
儲備液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 儲存時，請在 6 個月內(nèi)使用，-20°C 儲存時，請在 1 個月內(nèi)使用。
以下溶解方案都請先按照 In Vitro 方式配制澄清的儲備液，再依次添加助溶劑：
——為保證實驗結(jié)果的可靠性，澄清的儲備液可以根據(jù)儲存條件，適當(dāng)保存；體內(nèi)實驗的工作液，建議您現(xiàn)用現(xiàn)配，當(dāng)天使用； 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比；如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象，可以通過加熱和/或超聲的方式助溶
請依序添加每種溶劑： 0.5% CMC-Na/saline water
Solubility: 11 mg/mL (29.59 mM); Suspended solution; Need ultrasonic
請依序添加每種溶劑： PBS
Solubility: 10 mg/mL (26.90 mM); Suspended solution; Need ultrasonic
請依序添加每種溶劑： 10% DMSO 40% PEG300 5% Tween-80 45% saline
Solubility: ≥ 1.25 mg/mL (3.36 mM); Clear solution
請依序添加每種溶劑： 10% DMSO 90% (20% SBE-β-CD in saline)
Solubility: ≥ 1.25 mg/mL (3.36 mM); Clear solution
參考文獻(xiàn)
[1]. Cai Y, et al. Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo. J Nat Med. 2014 Jan;68(1):53-62. [Content Brief]
注：產(chǎn)品僅用于科研
關(guān)聯(lián)品牌
MCE(MedChemExpress)是科研化學(xué)品和生物活性化合物供應(yīng)商。MCE的產(chǎn)品范圍覆蓋各種抑制劑、化合物庫、重組蛋白等各類活性分子。我們專注于生物活性化合物，擁有多年的發(fā)展歷程和豐富的行業(yè)經(jīng)驗，專業(yè)、高效的企業(yè)理念鑄造了MCE在行業(yè)的地位。我們的研發(fā)團(tuán)隊擁有眾多的化學(xué)家和生物學(xué)家，從產(chǎn)品的HNMR數(shù)據(jù)解析到生物活性數(shù)據(jù)，從客戶的詢價到產(chǎn)品的售后服務(wù)，MCE擁有著完善的管理體系，從而保證我們的服務(wù)更加高效、準(zhǔn)確。MCE為醫(yī)藥行業(yè)的發(fā)展注入了新的活力，我們是您研發(fā)工作中值得信賴的伙伴！MCE致力于為客戶提供新穎齊全的高品質(zhì)小分子活性化合物。50,000多種特異...
查看更多留言咨詢
您訪問的Berberine chloride (鹽酸小檗jian）產(chǎn)品信息，由杭州昊鑫生物科技股份有限公司自行發(fā)布提供，產(chǎn)品價格為面議，如您想了解更多關(guān)于Berberine chloride (鹽酸小檗jian）型號、參數(shù)、用途等信息，歡迎咨詢。
該內(nèi)容的真實性、準(zhǔn)確性和合法性由發(fā)布會員負(fù)責(zé)，為保障安全，建議您在購買相關(guān)產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)以及產(chǎn)品質(zhì)量！
相關(guān)分類
該廠商其他產(chǎn)品
相關(guān)技術(shù)文章
隨時掌握行業(yè)動態(tài)
采購中心
采購專員1對1咨詢
*您想獲取產(chǎn)品的資料：
個人信息：
淮滨县|
巧家县|
平度市|
台北县|
通山县|
德保县|
柳州市|
广汉市|
渝北区|
陇川县|
赤水市|
长顺县|
桂林市|
阜阳市|
广丰县|
长海县|
区。|
延安市|
华蓥市|
余干县|
台安县|
清水县|
兰州市|
大余县|
遵化市|
佛山市|
晋城|
荔波县|
谷城县|
肃南|
古蔺县|
吉林省|
盈江县|
溧水县|
罗江县|
化隆|
肇庆市|
松桃|
卢湾区|
耒阳市|
刚察县|
用戶評論
發(fā)布評論